In this free webinar, learn how simplifying supply chain management can accelerate the advancement of CRISPR-based therapies, reduce risk and ultimately bring therapies to market faster. Attendees ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

Synthego’s CEO and co-founder Paul Dabrowski used to be lead digital designer at SpaceX. Now that he’s applying his engineering talents to intracellular space, he hopes to contribute to dramatic cost ...

CRISPR Therapeutics now has an approved product in its portfolio in Casgevy. The treatment has the potential to be a game changer for the company's business. Even with more treatments in its portfolio ...

Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

WEST LAFAYETTE, Ind. — More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, revolutionizing the ability to edit genes and ...

If I asked you to name some of your favorite natural treats, there’s a good chance you’d mention coffee, chocolate, or fruit. Now flip the script: think of a healthy veggie that you know you should ...